Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.22 -0.89 (-2.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

28 29 Next >

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

May 17, 2024

The Benzinga Stock Whisper highlights five stocks weekly that are seeing increased interest from readers.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 17, 2024

Via Benzinga

Smart Money Is Betting Big In VKTX Options ↗

May 17, 2024

Via Benzinga

Is Viking Therapeutics Stock a Buy? ↗

May 17, 2024

The stock could have room to soar higher if VK2735 obtains approval from regulators.

Via The Motley Fool

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗

May 17, 2024

With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.

Via InvestorPlace

Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗

May 15, 2024

Via Benzinga

How Is The Market Feeling About Viking Therapeutics? ↗

May 14, 2024

Via Benzinga

Viking Therapeutics's Options Frenzy: What You Need to Know ↗

May 08, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years ↗

May 01, 2024

Via Benzinga

Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000 ↗

May 16, 2024

Top small-cap stocks to buy Viking Therapeutics, Celsius and Hippo make waves in the weight loss, energy drink, and insurance tech sectors.

Via InvestorPlace

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025 ↗

May 14, 2024

These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet.

Via InvestorPlace

How Viking Therapeutics Stock Could 30x ↗

May 13, 2024

This mid-cap biopharma may one day be a titan of the industry.

Via The Motley Fool

Is Viking Therapeutics the Best Biotech Stock for You? ↗

May 13, 2024

With good mid-stage results and plenty of cash, Viking could be a winner.

Via The Motley Fool

The 3 Best Russell 2000 Stocks to Buy in May 2024 ↗

May 10, 2024

If you are looking for investments that will deliver high returns, these are the best Russell 2000 stocks to buy for your portfolio.

Via InvestorPlace

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 ↗

May 09, 2024

The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.

Via InvestorPlace

Check Out What Whales Are Doing With VKTX ↗

April 30, 2024

Via Benzinga

Can This High-Flying Stock 10x in 10 Years? ↗

April 28, 2024

This midcap biotech could see huge success ahead -- or disappointment.

Via The Motley Fool

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare ↗

May 07, 2024

Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.

Via InvestorPlace

Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon

May 06, 2024

Eli Lilly stock continues to move higher after the company reported continuing momentum for its flagship GLP-1 weight loss drugs

Via MarketBeat

Eli Lilly Raised Its Outlook. Is the Stock a Buy Now? ↗

May 04, 2024

The anti-obesity medication stock is way up, and there could be more fuel in the tank.

Via The Motley Fool

What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks ↗

May 02, 2024

Data indicates that many more Americans have become aware of the dangers of obesity. Here are the best weight loss stocks to buy now.

Via InvestorPlace

Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge ↗

May 01, 2024

A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.

Via InvestorPlace

Viking Therapeutics Unusual Options Activity ↗

April 26, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 30, 2024

Via Benzinga

Is Viking Therapeutics Incredibly Undervalued? ↗

April 28, 2024

The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.

Via The Motley Fool

1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst ↗

April 28, 2024

Tom Lee of Fundstrat Global Advisors thinks the small-cap Russell 2000 could climb 50% by the end of 2024.

Via The Motley Fool

3 Biotech Stocks to Buy on the Dip: April 2024 ↗

April 26, 2024

With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip.

Via InvestorPlace

3 Millionaire-Maker Biotech Stocks ↗

April 25, 2024

The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.

Via The Motley Fool

VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024 ↗

April 24, 2024

VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO ↗

April 24, 2024

Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 cents by 7.14%. Research and development expenses were $24.1 million for the...

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

All News about Viking Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today